Table 2.

Baseline patient characteristics and patient reported outcome scores

	Mean or N
Total # Patients	33
Age	45 (range 32–72)
Gender (Female/Male)	14/19
1 Level Injection	8
2 Level Injection	16
3 Level Injection	9
Baseline NRS	5.2 ± 0.4
Baseline SF-36	53.4 ± 2.6
Baseline ODI	36.7 ± 2.6